Connect with us

Technology

The World’s Most Bionic and Intelligent Panda Cub Robot Spotlight at CES 2025: To Deliver Psychological Support and Robot-Assisted Therapy

Published

on

LAS VEGAS, Jan. 7, 2025 /PRNewswire/ — Chinese Startup Unveils The Most Advanced Biomimetic Affective AI Pandas 

Imagine a world filled with panda cubs, where you can choose one as your own perfect pet. They tend to you anytime you want, and listen to you all the time. They not only understand what you are saying, but also response to you in a way based on the personality traits you want them to be. The more you hug, cuddle, or stroke them, the happier they become, growing more attached to you even during moments of loneliness or sadness. While owning a real panda cub may be out of reach, a Chinese company is making this dream a reality through advanced robotics.

At CES 2025, a Shenzhen-based company Mind with Heart Robotics Co., Ltd. (known as Wuxin) unveiled its latest product:

AnAn, an adorable bionic panda cub. AnAn reacts to a user’s touch with unique sounds based on where it’s petted, owing to its whole set of realistic and soft fur covering more than 10 tactile sensing suites. Designed with an intelligent “AI Brain”, AnAn is an ideal companion for users. This panda cub equips with core & long-term memory and reminder functions, making it a “personal assistant” for seniors. AnAn also comes with its dedicated app, allowing users to personalize their panda’s name, voice, and personality while sharing stories and experiences with a global community of “panda owners.”

Apart from its cute and attractive appearance, AnAn holds significant potential in healthcare, such as providing companionship for elderly patients with cognitive decline, helping reduce care costs, and improving their independence and quality of life. In addition, the AI panda serves as an engaging and educational companion, fostering emotional growth and improving social skills in children. It also provides stress relief for professionals and young individuals facing loneliness, offering the perfect solution for those who wish to own a pet but lack the time to care for one.

With its blend of advanced AI technology and heartwarming design, AnAn is set to redefine the future of companionship, offering users a unique and emotionally enriching experience.

The Business of Battling Loneliness: A Promising Market for AI-powered Plush Toys

As aging populations and mental health issues become more severe, the demand for loneliness reduction and psychological support has reached unprecedented levels. Groups such as the elderly living alone, single individuals, and socially anxious individuals, seek understanding and empathy. Special groups, such as patients with depression, cognitive disorders, or autism, also have strong needs for psychological support. “In China, over 100 million people fall into these demographics, and globally, the number shall be tragically multiplied by five,” said Dr. Zhang Jiaming, founder and CEO of Wuxin. “We firmly believe that biomimetic AI pets with affective intelligence become indispensable friends and personal assistants for mankind worldwide. And AnAn can be an ideal robot to deliver psychological support and robot-assisted therapy to global customers.”

Unlike human interactions, robots eliminate concerns about social stigma, embarrassment, or prejudice, providing stress-free conversations. They are also increasingly utilized in therapeutic contexts for psychological and cognitive challenges.

Many Chinese manufacturers have also launched AI-powered plush toys, with some companies reporting shipments of 20,000 to 30,000 units. These products primarily target young people and elderly people seeking to alleviate loneliness by owning an AI-powered pet.

According to market research firm Contrive Datum Insights, the global AI toys market is projected to reach $35.11 billion by 2030.

However, Dr. Zhang believes current products fall short of expectations. “Most AI pets on the market are overpriced, often exceeding $1,000, with limited realism and intelligence in interactions. Our products will deliver ‘Three Highs’, i.e., high cost-effectiveness, high bionic fidelity, and high affective intelligence, to attract and benefit more customers,” said Dr. Zhang. Wuxin has partnered with world-leading manufacturers, brand channels, and psychological and healthcare experts to overcome key challenges in bionic craftsmanship, cost, and production capacity, to set new industry standards.

Ambitious Plans for 2025 Mass Production

Industrial robots are no longer enough to satisfy the ambitions of Chinese companies. Robots with enhanced lifelike qualities, better communication, and interactive capabilities—especially those designed for home environments and elder care—are emerging as a new development trend. In the future, service and personal robots are expected to be widely adopted in areas such as customer service, hospitality, entertainment, healthcare, and elder care.

A complete supply chain system and supporting government incentive policies provide convenience for Chinese companies. Located in the innovation hub of China’s Greater Bay Area, Wuxin benefits from a robust industrial ecosystem in cities such as Hong Kong, Shenzhen, Dongguan, and Zhongshan. Government support is also abundant; for example, Shenzhen’s 2022 initiative to develop intelligent robotics clusters included subsidies of up to 3 million RMB (~$410,000).

Dr. Zhang, who earned his Ph.D.at the University of Sheffield under globally renowned AI & robotics experts Prof. Noel Sharkey and Dr. Amanda Sharkey, has over a decade of experience in robotics, AI, affective computing, and human-robot interaction. He has led or participated in the development of more than 20 different forms of interactive robots. From 2015 to 2019, he and his team developed the world’s first biomimetic panda robot. This robot was used in a preliminary study on the feasibility of a panda robot with 20 dementia patients at a day care center (JCCPA in Hong Kong), and it garnered significant media attention in Mainland China. Currently Wuxin has assembled a team of top-tier talent from universities such as the University of Nottingham, CUHK and Peking University, and has filed over 30 patents.

“Our philosophy is rooted in our belief in 3S- ‘Simulation-Stimulus-Social Creatures,’ meaning creating social beings through interactive stimuli based on bionics. As a result, all our products could be labeled as highly biomimetic and emotionally intelligent,” said Dr. Zhang. The Wuxin product line also includes other forms, and all products will be launched in 2025.

As technology advances and demand grows, Biomimetic AI Pets with Affective Intelligence are poised to become a ubiquitous part of daily life, transforming from cinematic fantasies into reality. Ambitious Chinese companies like Wuxin are making quiet yet significant strides toward this future.

About Wuxin

Mind with Heart Robotics Co., Ltd.

Address: 1601A, 8th Building, Qianhai Excellence Financial Center (Phase I), No. 5033 Menghai Avenue, Nanshan Street, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen, Guangdong Province, China.

Media Contact

CEO Dr. Zhang: 0086-13530502919

Email: zhangjiaming@wxbionics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-worlds-most-bionic-and-intelligent-panda-cub-robot-spotlight-at-ces-2025-to-deliver-psychological-support-and-robot-assisted-therapy-302345109.html

SOURCE Mind With Heart Robotics

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

TriNetX’s Founding CEO Announces Plans to Step Down

Published

on

By

After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX’s Board

CAMBRIDGE, Mass., Jan. 9, 2025 /PRNewswire/ — TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company’s Founder, President and CEO, will step down from his operating role on March 31, 2025. Gadi founded TriNetX in 2014 and has served as President and CEO in the succeeding 11 years. Gadi will continue to serve on TriNetX’s Board of Directors and will be an Advisor to Carlyle, TriNetX’s majority investor.

“It has been an honor to build TriNetX and be part of such an outstanding team. I want to thank TriNetX’s employees, customers, and shareholders for the support they have shown me. With the talent and passion of our people I am immensely confident in TriNetX’s continued success,” said Lachman. “Together, we have built the largest global platform for clinical research, with data from over 25 countries and tens of millions of queries a month. Our solutions are moving clinical research to a whole different level and saving lives on a massive scale, across all therapeutic areas.”

During the transition period, Jeff Margolis, a current TriNetX Director, will serve as Executive Chairman to ensure continuity in leadership and governance while a CEO search is conducted.

Margolis said, “I have had the distinct privilege of serving on the Board alongside Gadi and partnering with him for 11 years. On behalf of the Board, we thank Gadi for shaping and leading TriNetX to become the world’s top ecosystem of real-world data and real-world evidence serving life sciences and the broader healthcare industry. I look forward to working with him and the rest of the Board over the next months to execute a successful transition of leadership.”

Joe Bress, Partner and Global Co-Head of Healthcare for Carlyle, TriNetX’s lead investor, added, “We have been thrilled to partner with Gadi since our initial investment in TriNetX over four years ago. Thanks to his disciplined leadership, TriNetX is one of the few companies that has sustained profitability even during periods of high growth. Gadi has built the company up to an exciting point, paving the way for a new leader to take the business into its next chapter of growth and success.”

Through this leadership transition, TriNetX remains steadfast in its mission to advance global healthcare through the power of real-world data. The Board, leadership team, and employees are united in their commitment to driving continued innovation and delivering success for customers and partners, all while building on Gadi’s exceptional legacy.

About TriNetX, LLC

TriNetX is a global network of healthcare organizations and life sciences companies dedicated to advancing real-world research and expediting the development of new therapies. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation. For more information, please visit TriNetX at www.trinetx.com or follow TriNetX on LinkedIn.

Media Contact
TriNetX
Michelle Fleming, Chief Marketing Officer
Email: Michelle.Fleming@TriNetX.com

Logo – https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/trinetxs-founding-ceo-announces-plans-to-step-down-302347367.html

Continue Reading

Technology

Stellus Private Credit BDC Announces $0.36 First Quarter 2025 Regular Dividend, Payable Monthly in Increments of $0.12 in January, February, and March 2025

Published

on

By

HOUSTON, Jan. 9, 2025 /PRNewswire/ — Stellus Private Credit BDC (“the Company”) announced that its Board of Trustees has declared a monthly dividend of $0.12 for each of January, February, and March, totaling $0.36 per share in the aggregate for the first quarter of 2025. The regular dividend of $0.36 per share will be paid to shareholders of record in January, February, and March 2025.

Summary of First Quarter 2025 Regular Monthly Dividends

Declared

Record Date

Payment Date

Amount per Share

1/9/2025

1/10/2025

1/31/2025

$0.12

1/9/2025

2/3/2025

2/28/2025

$0.12

1/9/2025

3/3/2025

3/31/2025

$0.12

About Stellus Private Credit BDC

The Company is an externally-managed, closed-end, non-diversified investment management company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation by investing primarily in private middle-market companies (typically those with $5.0 million to $50.0 million of EBITDA (earnings before interest, taxes, depreciation and amortization)) through first lien (including unitranche) loans, second lien loans and unsecured debt financing, with corresponding equity co-investments. The Company’s investment activities are managed by its investment adviser, Stellus Private BDC Advisor, LLC.

Forward-Looking Statements

Statements included herein may contain “forward-looking statements” which relate to future performance or financial condition. Statements other than statements of historical facts included in this press release, including statements about COVID-19 and its impacts, may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of assumptions, risks and uncertainties, which change over time. Actual results may differ materially from those anticipated in any forward-looking statements as a result of a number of factors, including those described from time to time in filings by the Company with the Securities and Exchange Commission including the final prospectus that will be filed with the Securities and Exchange Commission. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Contacts
Stellus Private Credit BDC
W. Todd Huskinson, Chief Financial Officer
(713) 292-5414
thuskinson@stelluscapital.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/stellus-private-credit-bdc-announces-0-36-first-quarter-2025-regular-dividend-payable-monthly-in-increments-of-0-12-in-january-february-and-march-2025–302347311.html

SOURCE Stellus Private Credit BDC

Continue Reading

Technology

MongoDB, Inc. to Present at the 27th Annual Needham Growth Conference

Published

on

By

NEW YORK, Jan. 9, 2025 /PRNewswire/ — MongoDB, Inc. (NASDAQ: MDB) today announced that Chief Operating Officer and Chief Financial Officer, Michael Gordon, and Senior Vice President of Finance, Serge Tanjga, will present virtually at the 27th Annual Needham Growth Conference.

The MongoDB presentation is scheduled for Thursday, January 16, 2025, at 3:45 p.m. Eastern Time. A live webcast of the presentation will be available on the Events page of the MongoDB investor relations website at https://investors.mongodb.com/news-events/events. A replay of the webcast will also be available for a limited time.

About MongoDB
Headquartered in New York, MongoDB’s mission is to empower innovators to create, transform, and disrupt industries by unleashing the power of software and data. Built by developers, for developers, MongoDB’s developer data platform is a database with an integrated set of related services that allow development teams to address the growing requirements for today’s wide variety of modern applications, all in a unified and consistent user experience. MongoDB has tens of thousands of customers in over 100 countries. The MongoDB database platform has been downloaded hundreds of millions of times since 2007, and there have been millions of builders trained through MongoDB University courses. To learn more, visit mongodb.com.

Investor Relations
Brian Denyeau
ICR for MongoDB
646-277-1251
ir@mongodb.com

Media Relations
MongoDB PR
press@mongodb.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/mongodb-inc-to-present-at-the-27th-annual-needham-growth-conference-302347475.html

SOURCE MongoDB, Inc.

Continue Reading

Trending